Clinical Trials Browser

Phase 3 × OTHER_GOV × Myelodysplastic Syndromes × Clear all

NCT03978364 2019-06-07

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Phase 3 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute